| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0950268812001148 |
| P698 | PubMed publication ID | 22691710 |
| P50 | author | Cathriona Kearns | Q57548949 |
| Nick Andrews | Q91506784 | ||
| P2093 | author name string | C Moore | |
| J Ellis | |||
| J McMenamin | |||
| C Robertson | |||
| D Rh Thomas | |||
| S Cottrell | |||
| D M Fleming | |||
| B Smyth | |||
| M Zambon | |||
| H Durnall | |||
| R G Pebody | |||
| J M Watson | |||
| W Carman | |||
| P Sebastian-Pillai | |||
| P2860 | cites work | Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study | Q21144621 |
| Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities | Q28741469 | ||
| Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. | Q30357784 | ||
| Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus. | Q30381905 | ||
| Estimating influenza vaccine effectiveness using routinely collected laboratory data. | Q30382480 | ||
| Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England | Q30397257 | ||
| Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010 | Q30404923 | ||
| H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study | Q30412103 | ||
| Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study | Q30414952 | ||
| Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons | Q36964157 | ||
| Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study | Q40342526 | ||
| Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study | Q44004735 | ||
| Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. | Q44222661 | ||
| A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season | Q47843797 | ||
| Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. | Q50801938 | ||
| Influenza vaccination status is not associated with influenza testing among children: implications for observational studies of vaccine effectiveness. | Q53078945 | ||
| Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. | Q54479219 | ||
| P433 | issue | 3 | |
| P921 | main subject | United Kingdom | Q145 |
| pandemic | Q12184 | ||
| pandemic prevention | Q88903302 | ||
| P304 | page(s) | 620-630 | |
| P577 | publication date | 2012-06-13 | |
| P1433 | published in | Epidemiology and Infection | Q5382708 |
| P1476 | title | Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom | |
| P478 | volume | 141 |
| Q30427950 | Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques |
| Q35211657 | Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany |
| Q39530697 | Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011. |
| Q38819920 | Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review |
| Q53283393 | Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis. |
| Q30401497 | Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus |
| Q34274933 | Effectiveness of seasonal influenza vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel in 2010-2013. |
| Q34451202 | Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies |
| Q36251706 | Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study |
| Q34274852 | Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥ 50 years |
| Q46200283 | Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season |
| Q51174772 | Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method--experience across the 2010/11 season. |
| Q38660898 | Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines. |
| Q90927798 | Exploring indirect protection associated with influenza immunization - A systematic review of the literature |
| Q34786909 | Field seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza season |
| Q27009478 | Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults |
| Q21144595 | Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study |
| Q52845428 | Hintergrundpapier der STIKO: Evaluation der bestehenden Influenzaimpfempfehlung für Indikationsgruppen und für Senioren (Standardimpfung ab 60 Jahren). |
| Q30383312 | Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. |
| Q56791503 | Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza |
| Q30373642 | Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children. |
| Q34778408 | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review |
| Q39340731 | Repeated annual influenza vaccination and vaccine effectiveness: review of evidence |
| Q41053372 | Social class based on occupation is associated with hospitalization for A(H1N1)pdm09 infection. Comparison between hospitalized and ambulatory cases. |
| Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
| Q38639994 | The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis |
| Q60912426 | The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis |
| Q35097579 | Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011-2012 Season |
| Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |
Search more.